Who Paid My Doc
Kogenate FS
Drug Hematology
NDC 0026-3792-20
General payments
$62,292
Research payments
$132,380
Through program year 2023, $62,292 in general payments and $132,380 in research payments were reported against Kogenate FS (Hematology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | General | $199 | 5 |
| 2022 | General | $1,114 | 19 |
| 2021 | General | $347 | 17 |
| 2021 | Research | $59,910 | 2 |
| 2020 | General | $14 | 1 |
| 2019 | General | $60,618 | 82 |
| 2019 | Research | $72,470 | 2 |
Breakdown
Each share is of general payments naming this product in 2023.
Each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2023 where a state was reported.
Records
124 general · 4 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.